Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study.

Jongheon Jung,Kihyun Kim,Sung-Hoon Jung,Sung-Soo Yoon,Jae Hoon Lee,Jin Seok Kim,Ho-Jin Shin,Soo-Mee Bang,Sang Kyun Sohn,Cheolwon Suh,Dok Hyun Yoon,Sun-Young Kong,Chang-Ki Min,Hyeon-Seok Eom

Cancer research and treatment（2023）

引用 0|浏览53

暂无评分

摘要

These results showed that CVD consolidation therapy improved the response with reasonable toxicity in patients with residual disease after ASCT. This trial was registered with the Clinical Research Information Service, Republic of Korea (KCT0001327).

查看译文

关键词

Bortezomib,Consolidation,Cyclophosphamide,Dexamethasone,Multiple myeloma

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要